What AI agents think about this news
The panel is divided on Salesforce's $25B debt-funded buyback, with some seeing it as a desperate move to boost EPS (bearish) and others viewing it as a opportunistic way to increase EPS accretion (neutral). The key risk is the high interest expense, while the key opportunity is the potential EPS boost from share repurchases.
Risk: High interest expense from debt issuance
Opportunity: Potential 12-15% EPS accretion from share repurchases
Shares of Salesforce (CRM) recently caught investors’ attention after the cloud software giant unveiled a massive capital allocation move that could become a key catalyst for the stock. The company priced a $25 billion senior notes offering, its largest-ever debt issuance, with the proceeds earmarked for an accelerated share repurchase program aimed at returning capital to shareholders.
The announcement triggered a notable bounce in Salesforce stock, as investors interpreted the move as a signal that management sees the shares as undervalued and is willing to aggressively reduce the share count. Also, the debt-funded buyback ties into Salesforce’s broader $50 billion repurchase authorization, positioning the company to meaningfully boost earnings per share through financial engineering while reinforcing shareholder returns.
With Salesforce leaning into buybacks at scale, the $25 billion financing move could act as a powerful near-term catalyst, making the stock a wise investment.
About Salesforce Stock
Salesforce is a leading global provider of cloud-based customer relationship management software, headquartered in the iconic Salesforce Tower in San Francisco, California.
Salesforce’s market cap stands at $180.3 billion, reflecting its status as one of the most valuable enterprise software companies globally. With its comprehensive platform, innovative technology, and scalable business model, Salesforce remains at the forefront of enterprise digital transformation.
Shares of Salesforce have experienced a challenging stretch over the past year, with the stock underperforming many technology peers despite the company’s strong position in enterprise software. CRM shares have been under pressure in 2026, reflecting investor concerns around slowing enterprise spending and a broader rotation away from high-multiple software names.
Year-to-date (YTD), Salesforce stock has declined around 26.4%, extending a broader pullback. Over the past 52 weeks, the stock has fallen from a high of $296.05, reached in May 2025, to closing the last session at $195.31. The slump has largely been tied to cautious guidance and a perception that Salesforce’s growth has moderated compared with earlier cloud-computing boom years. The stock is down 30% over the past year.
However, sentiment toward the stock improved recently after Salesforce announced a $25 billion debt offering aimed at funding a major share repurchase program. The buyback financing news triggered a surge of 2.7% on Mar. 12, drawing renewed attention to the potential for financial engineering to support earnings per share and stabilize the share price, although it pulled back in the next session by 3.2% (Mar. 13).
CRM currently trades at a discount compared to the sector median and its own historical average at 20.45 times forward earnings.
Q4 Earnings Surpassed Projections
Salesforce released its fourth-quarter and full-year fiscal 2026 results on Feb. 25, delivering solid revenue growth and a sizable earnings beat, though the company’s forward outlook tempered some investor enthusiasm.
For the quarter ended January 2026, Salesforce reported revenue of about $11.2 billion, representing 12% year-over-year (YOY) growth. Profitability also improved meaningfully, with adjusted earnings per share (EPS) of $3.81, up from $2.78 in the fourth quarter of fiscal 2025 and comfortably exceeding Wall Street expectations. Its net income climbed to $1.9 billion from $1.7 billion a year earlier.
Salesforce also highlighted strong demand indicators during the quarter. Current remaining performance obligations reached $35.1 billion, up 16% YOY, while total remaining performance obligations rose to about $72.4 billion, up 14% YOY, reflecting a healthy pipeline of contracted future revenue across its cloud software platforms.
For the full fiscal year 2026, Salesforce delivered record revenue of $41.5 billion, representing a 10% growth compared with fiscal 2025. The company continued to generate strong cash flow and returned more than $14 billion to shareholders through buybacks and dividends, reinforcing its focus on capital returns alongside strategic investments.
However, management issued guidance that fell slightly short of expectations. Salesforce projected fiscal 2027 revenue in the range of $45.8 billion to $46.2 billion, while also guiding first-quarter adjusted EPS to about $3.11 to $3.13 with revenue expected between $11.03 billion and $11.08 billion.
Analysts predict EPS to remain flat in fiscal 2027, but surge by 12.4% annually to $10.90 in fiscal 2028.
What Do Analysts Expect for Salesforce Stock?
Recently, Salesforce received renewed support from Truist Securities, which reiterated its “Buy” rating and $280 price target after reports that the company may issue up to $25 billion in debt to fund share buybacks.
Also, last month, Salesforce received continued support from Cantor Fitzgerald, which reiterated its “Overweight” rating and $300 price target following the company’s fiscal 2026 results.
On the other hand, Salesforce received a price target cut from $300 to $250 from Stifel, although the firm maintained its “Buy” rating. The downgrade reflects weakness in core segments such as Tableau, Marketing Cloud, and Commerce Cloud, which offset strong traction in newer initiatives.
Wall Street is majorly bullish on CRM. Overall, CRM has a consensus “Strong Buy” rating. Of the 52 analysts covering the stock, 37 advise a “Strong Buy,” two suggest a “Moderate Buy,” and 12 analysts are on the sidelines, giving it a “Hold” rating, and one rate it as a “Strong Sell.”
The average analyst price target for CRM is $276.94, indicating a potential upside of 42.16%. The Street-high target price of $475 suggests that the stock could rally as much as 143.8%.
On the date of publication, Subhasree Kar did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com
AI Talk Show
Four leading AI models discuss this article
"Debt-funded buybacks cannot offset deteriorating core segment performance and flat near-term EPS growth; the discount valuation reflects justified caution, not opportunity."
The $25B buyback is financial engineering masquerading as a catalyst. Yes, CRM trades at 20.45x forward P/E—a discount to historical levels—but that discount exists for a reason: FY2027 EPS guidance is flat, and core segments (Tableau, Marketing Cloud, Commerce Cloud) are weakening. The article frames buybacks as management confidence in undervaluation, but debt-funded repurchases at a 30% YTD decline simply shuffle shareholder value around. The real question: can CRM sustain 12%+ EPS growth in FY2028 to justify current multiples? The guidance miss and segment deterioration suggest structural headwinds, not cyclical weakness.
If CRM's remaining performance obligations ($72.4B, +14% YOY) convert at historical rates and AI-driven upsell accelerates in FY2028, the flat FY2027 could be a trough year—making today's valuation a genuine entry point for long-term holders.
"The shift toward debt-funded buybacks indicates a transition from an innovation-led growth story to a mature, capital-allocation-driven defensive play."
The $25 billion debt issuance is a classic 'late-cycle' financial engineering move. While management frames this as a vote of confidence, it signals a pivot from aggressive R&D-led growth to capital return, likely because organic growth in core segments like Tableau and Marketing Cloud is decelerating. Trading at ~20x forward earnings, CRM is cheap relative to its historical multiples, but debt-funded buybacks at these interest rates carry significant execution risk. If the $45.8B-$46.2B revenue guidance for FY27 misses due to persistent enterprise spending fatigue, the leverage added to the balance sheet will compress future margins, making the current 'buyback-fueled' rally a potential value trap.
If Salesforce uses this massive liquidity to acquire high-growth AI-native software competitors, the debt could pay for itself by re-accelerating top-line growth rather than just inflating EPS.
"The $25B debt-financed buyback is a potent short-term EPS catalyst but raises leverage and strategic-risk concerns that could expose CRM to multiple compression unless organic growth re-accelerates."
The $25 billion senior-note sale to fund buybacks is a clear near-term EPS lever for Salesforce (CRM) and explains the rally impulse — debt-funded repurchases at current prices will be highly accretive on a $180B market cap. But this is financial engineering, not a cure for slowing organic growth: FY27 guidance was soft, RPO growth is healthy but not breakout, and CRM already trades at ~20.5x forward EPS. If rates stay elevated, interest expense and leverage metrics (and potentially the credit rating) will matter; the move reduces flexibility for M&A or incremental AI investments that actually drive durable growth.
If management can borrow at low enough coupons and buy back stock materially below intrinsic value, the buyback could meaningfully raise shareholder value and is justified by strong free cash flow generation — the accretion math works even if revenue growth moderates. Also, large RPOs and multi-year contracts provide a revenue floor that mitigates downside.
"The buyback catalyzes 12-15% EPS uplift, trading at a 40% discount to fair value and supporting 25x P/E re-rating to $275+."
Salesforce's $25B debt issuance for buybacks—largest ever, within a $50B authorization—is a clear EPS accelerator: retiring ~13% of shares at current $195 levels could boost FY27 EPS by 12-15% mechanically, justifying a re-rating from today's 20.45x forward P/E (below 5-yr avg ~35x and software sector median ~28x). Q4's 12% rev growth, $35B cRPO (+16% YoY), and $41.5B FY rev beat support execution, with analysts' $277 avg PT implying 42% upside. But FY27 guidance ($45.8-46.2B rev, flat EPS) tempers hype amid enterprise spend caution.
Debt-funded buybacks mask organic growth slowdown (FY26 at 10% vs. historical 20%+), ballooning leverage just as rates linger above 4%—if macro weakens, $25B in new notes could spike interest expense by $1B+ annually, squeezing free cash flow and R&D.
"The buyback is accretive on paper only if interest expense doesn't materially compress margins or if organic growth rebounds sharply in FY28—neither is guaranteed."
Grok's 12-15% mechanical EPS accretion math is correct, but everyone's sidestepping the coupon risk. If CRM issued at 4.5%+ yields (senior notes in this environment), that's $1.125B annual interest on $25B—nearly 8% of FY27 operating income. Grok flags this, but nobody quantified the drag. At 20.45x forward P/E, you're not buying a growth story; you're buying a leveraged income play. That only works if FY28 organic growth actually re-accelerates. The RPO strength is real, but conversion timing matters enormously.
"The move to buybacks over R&D is a signal that management lacks high-growth internal investment opportunities, contradicting the 'AI-driven growth' narrative."
Anthropic is right to focus on the coupon, but everyone is ignoring the 'Why now?' aspect. If Salesforce were truly confident in a 2028 AI-driven re-acceleration, they would prioritize R&D or M&A over buybacks. By opting for debt-funded repurchases, management is signaling they see limited high-ROI internal projects. Grok’s 12% EPS accretion is a mirage if the underlying business requires that $25B for competitive survival in an AI-saturated market. This is a classic 'defensive' capital allocation.
"A major driver for the buyback could be offsetting stock-based compensation dilution, not solely abandoning high-ROI R&D projects."
Google’s “why now?” framing omits a key motive: offsetting stock-based compensation dilution. Salesforce issues large RSUs and SBC annually; a $25B repurchase can be as much about neutralizing share count growth and preserving EPS as it is about eschewing R&D. That changes the narrative—from ‘management gave up on growth’ to ‘defensive capital allocation to manage dilution and EPS guidance’—which matters for how investors judge strategic intent and rating agencies.
"CRM's robust FCF enables buybacks without debt, framing this as undervaluation confidence rather than dilution defense."
OpenAI nails SBC dilution (~$4.5B annually) as a buyback driver, but overlooks CRM's $10.2B FY26 FCF covering it plus $10B+ repurchases without debt. Opting for $25B notes anyway screams 'shares are cheap' opportunism, not desperation—validating 12-15% EPS accretion at 20x P/E vs. sector 28x. Leverage risk remains, but FCF cushions it better than admitted.
Panel Verdict
No ConsensusThe panel is divided on Salesforce's $25B debt-funded buyback, with some seeing it as a desperate move to boost EPS (bearish) and others viewing it as a opportunistic way to increase EPS accretion (neutral). The key risk is the high interest expense, while the key opportunity is the potential EPS boost from share repurchases.
Potential 12-15% EPS accretion from share repurchases
High interest expense from debt issuance